Honasa Consumer is set to acquire a majority stake in hair therapy brand Fluence Pharma at a valuation of Rs 135 crore, according to economictimes.indiatimes.com. The deal marks a significant investment in the personal care segment, with the transaction expected to close soon. This move expands Honasa Consumer’s portfolio in the beauty and wellness sector.
The acquisition process involved detailed negotiations and due diligence, culminating in Honasa Consumer securing the majority ownership of Fluence Pharma. The hair therapy brand has gained traction for its specialized products, which attracted Honasa Consumer’s interest. The company aims to leverage Fluence Pharma’s market presence to enhance its offerings in the hair care category, as reported by economictimes.indiatimes.com.
This acquisition reflects the growing trend of consumer brands consolidating to capture a larger share of the personal care market in India. Comparable deals in the sector have seen increasing valuations, highlighting investor confidence in beauty and wellness products. Honasa Consumer’s move aligns with broader industry patterns where established players acquire niche brands to diversify and strengthen their market position, according to economictimes.indiatimes.com.
The deal is valued at Rs 135 crore, with the exact closing date yet to be announced. Honasa Consumer’s acquisition of Fluence Pharma is expected to be finalized within the current quarter, signaling continued consolidation activity in the Indian personal care industry, as detailed by economictimes.indiatimes.com.